A factor to consider is the ongoing treatment of HIV/AIDS patients with cotrimoxazole, a bacterial dhfr/dhps inhibitor used to treat respiratory tract infections and to prevent opportunistic infections. The gene discussed is DHFR; the disease is Respiratory tract infection.